These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 28067426)
21. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1. Li Y; Zhang J; Zhang W; Liu Y; Li Y; Wang K; Zhang Y; Yang C; Li X; Shi J; Su L; Hu D J Mol Histol; 2017 Dec; 48(5-6):357-366. PubMed ID: 28884252 [TBL] [Abstract][Full Text] [Related]
22. p75NTR silencing inhibits proliferation, migration, and extracellular matrix deposition of hypertrophic scar fibroblasts by activating autophagy through inhibiting the PI3K/Akt/mTOR pathway. Shi W; Wu Y; Bian D Can J Physiol Pharmacol; 2021 Apr; 99(4):349-359. PubMed ID: 32726570 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA H19 acts as a microRNA-194 sponge to inhibit the apoptosis and promote the proliferation of hypertrophic scar fibroblasts. Liu B; Lin L; Yu S; Xia R; Zheng L Can J Physiol Pharmacol; 2021 Dec; 99(12):1288-1297. PubMed ID: 34310900 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA GAS5 inhibits the proliferation and induces the apoptosis of hypertrophic scar fibroblasts by sponging miR-21. Luo HB; Cao Y; Tao MC; Yang XH; Chen J J Biol Regul Homeost Agents; 2021; 35(1):283-288. PubMed ID: 33594853 [No Abstract] [Full Text] [Related]
25. LncRNA PICSAR binds to miR-485-5p and activates TGF-β1/Smad to promote abnormal proliferation of hypertrophic scar fibroblasts (HSFs) and excessive deposition of extracellular matrix (ECM). Xu S; Dong W; Shi Y Med Mol Morphol; 2021 Dec; 54(4):337-345. PubMed ID: 34255190 [TBL] [Abstract][Full Text] [Related]
26. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway. Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490 [TBL] [Abstract][Full Text] [Related]
27. Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis. Huang C; Yang Y; Liu L Physiol Genomics; 2015 Oct; 47(10):463-9. PubMed ID: 26269497 [TBL] [Abstract][Full Text] [Related]
28. siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue. Wang YW; Liou NH; Cherng JH; Chang SJ; Ma KH; Fu E; Liu JC; Dai NT J Invest Dermatol; 2014 Jul; 134(7):2016-2025. PubMed ID: 24670383 [TBL] [Abstract][Full Text] [Related]
29. Exosomal miR‑194 from adipose‑derived stem cells impedes hypertrophic scar formation through targeting TGF‑β1. Xu Z; Tian Y; Hao L Mol Med Rep; 2024 Dec; 30(6):. PubMed ID: 39329201 [TBL] [Abstract][Full Text] [Related]
30. MiR-3613-3p inhibits hypertrophic scar formation by down-regulating arginine and glutamate-rich 1. Li L; Han W; Chen Y; Chen Y Mol Cell Biochem; 2021 Feb; 476(2):1025-1036. PubMed ID: 33165823 [TBL] [Abstract][Full Text] [Related]
31. tRNA‑derived small RNAs: A novel class of small RNAs in human hypertrophic scar fibroblasts. Zhang Y; Deng Q; Tu L; Lv D; Liu D Int J Mol Med; 2020 Jan; 45(1):115-130. PubMed ID: 31939611 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7. Zhou X; Xie Y; Xiao H; Deng X; Wang Y; Jiang L; Liu C; Zhou R Biomed Pharmacother; 2018 Apr; 100():184-190. PubMed ID: 29428666 [TBL] [Abstract][Full Text] [Related]
33. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. Zhang K; Garner W; Cohen L; Rodriguez J; Phan S J Invest Dermatol; 1995 May; 104(5):750-4. PubMed ID: 7738352 [TBL] [Abstract][Full Text] [Related]
34. Blocking the MIR155HG/miR-155 axis reduces CTGF-induced inflammatory cytokine production and α-SMA expression via upregulating AZGP1 in hypertrophic scar fibroblasts. Li Y; Xiao Y; Han Y; Zhu H; Han J; Wang H Cell Signal; 2024 Aug; 120():111202. PubMed ID: 38729323 [TBL] [Abstract][Full Text] [Related]
35. Growth factor pathways in hypertrophic scars: Molecular pathogenesis and therapeutic implications. Lian N; Li T Biomed Pharmacother; 2016 Dec; 84():42-50. PubMed ID: 27636511 [TBL] [Abstract][Full Text] [Related]
36. Non-coding RNAs in hypertrophic scars and keloids: Current research and clinical relevance: A review. Su L; Han J Int J Biol Macromol; 2024 Jan; 256(Pt 1):128334. PubMed ID: 38007032 [TBL] [Abstract][Full Text] [Related]
37. Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway. Zhang Y; Shan S; Wang J; Cheng X; Yi B; Zhou J; Li Q Mol Cell Biochem; 2016 Feb; 413(1-2):109-18. PubMed ID: 26728998 [TBL] [Abstract][Full Text] [Related]
38. CircRNA_SLC8A1 alleviates hypertrophic scar progression by mediating the Nrf2-ARE pathway. Jin Y; He Y; Wu Y; Wang X; Lyu L; Zhang K; Ao C; Xu L Mol Biol Rep; 2024 Oct; 51(1):1067. PubMed ID: 39422836 [TBL] [Abstract][Full Text] [Related]
39. MRP1 knockdown down-regulates the deposition of collagen and leads to a reduced hypertrophic scar fibrosis. Li Y; Yang L; Zheng Z; Shi J; Wu X; Guan H; Jia Y; Tao K; Wang H; Han S; Gao J; Zhao B; Su L; Hu D J Mol Histol; 2015 Oct; 46(4-5):357-64. PubMed ID: 26092470 [TBL] [Abstract][Full Text] [Related]
40. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]